文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

EviGUIDE:宫颈癌图像引导自适应近距离放疗循证决策工具

EviGUIDE - a tool for evidence-based decision making in image-guided adaptive brachytherapy for cervical cancer.
PubMed 文献 · Radiother Oncol · 2023-06-16

研究开发了EviGUIDE决策支持系统,整合治疗计划剂量学信息、患者与治疗特征及基于EMBRACE-I研究1341例患者建立的6个Cox比例风险模型(1个肿瘤控制概率模型和5个正常组织并发症概率模型),用于预测局部晚期宫颈癌放疗结局,并对45例接受MR-IGABT的患者进行回顾性分析,显示约20%具有增加风险因素的患者亚群可从定量与可视化反馈中获益。

要点

  • EviGUIDE整合了基于EMBRACE-I研究1341例患者的1个肿瘤控制概率模型和5个正常组织并发症概率模型。
  • 系统提供肿瘤控制概率-正常组织并发症概率图,帮助可视化不同治疗计划的临床影响。
  • 对45例MR-IGABT患者的回顾性分析显示约20%具有增加风险因素的患者亚群可从中获益。

核心结论

  • 开发了一种新型数字化决策支持系统,可增强临床决策并促进个体化治疗,作为放疗领域新一代决策支持系统的概念验证。

研究设计与样本

  • 开发EviGUIDE决策支持系统,整合治疗计划系统剂量学信息、患者与治疗特征以及基于EMBRACE-I研究1341例患者数据的6个Cox比例风险模型。
  • 对45例接受MR-IGABT治疗的局部晚期宫颈癌患者进行回顾性分析。

主要发现

  • EviGUIDE整合了1个局部肿瘤控制概率模型和5个危及器官并发症正常组织并发症概率模型。
  • 系统提供肿瘤控制概率-正常组织并发症概率图,帮助用户可视化不同治疗计划的临床影响,并基于大型参考人群提供可达到剂量的反馈。
  • 回顾性分析45例接受MR-IGABT的患者显示,存在一个约20%具有增加风险因素的患者亚群,可从定量和可视化反馈中极大获益。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To develop a novel decision-support system for radiation oncology that incorporates clinical, treatment and outcome data, as well as outcome models from a large clinical trial on magnetic resonance image-guided adaptive brachytherapy (MR-IGABT) for locally advanced cervical cancer (LACC). METHODS: A system, called EviGUIDE, was developed that combines dosimetric information from the treatment planning system, patient and treatment characteristics, and established tumor control probability (TCP), and normal tissue complication probability (NTCP) models, to predict clinical outcome of radiotherapy treatment of LACC. Six Cox Proportional Hazards models based on data from 1341 patients of the EMBRACE-I study have been integrated. One TCP model for local tumor control, and five NTCP models for OAR morbidities. RESULTS: EviGUIDE incorporates TCP-NTCP graphs to help users visualize the clinical impact of different treatment plans and provides feedback on achievable doses based on a large reference population. It enables holistic assessment of the interplay between multiple clinical endpoints and tumour and treatment variables. Retrospective analysis of 45 patients treated with MR-IGABT showed that there exists a sub-cohort of patients (20%) with increased risk factors, that could greatly benefit from the quantitative and visual feedback. CONCLUSION: A novel digital concept was developed that can enhance clinical decision- making and facilitate personalized treatment. It serves as a proof of concept for a new generation of decision support systems in radiation oncology, which incorporate outcome models and high-quality reference data, and aids the dissemination of evidence-based knowledge about optimal treatment and serve as a blueprint for other sites in radiation oncology.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Ecker S, Kirisits C, Schmid M, et al. EviGUIDE - a tool for evidence-based decision making in image-guided adaptive brachytherapy for cervical cancer. Radiother Oncol. 2023. PMID: 37330055. doi:10.1016/j.radonc.2023.109748

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。